Intrinsic Value of S&P & Nasdaq Contact Us

Enveric Biosciences, Inc. ENVB NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
37/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — ENVB

Enveric Biosciences, Inc. (ENVB) has a market capitalization of $1.16M and trades at $1.95. The 52-week range is 1.75-17.844.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.1, Earnings Per Share (EPS) of $-36.24.

The stock has a beta of 0.33, operates in the Healthcare sector.

Trading Data
Current Price$1.95
52-Week Range1.75-17.844
Volume21.46K
Avg Volume (30D)364.5K
Market Cap$1.16M
Beta (1Y)0.33
Company
IPO Date2015-05-04
Employees5
CEOJoseph Edward Tucker
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS29405E5050
CUSIP29405E505
Income (Latest Year)
Gross Profit$-200.86K
EBITDA$-8.57M
Operating Income$-8.77M
Net Income$-12.13M
EPS$-36.24
EPS Diluted$-36.24
Shares Outstanding$334.72K
Balance Sheet (Latest Year)
Total Assets$5.1M
Current Assets$4.94M
Cash & ST Investments$4.68M
Total Liabilities$918.4K
Net Debt$-4.68M
Total Equity$4.18M
Valuation Ratios
P/E Ratio-0.1
P/B Ratio0.28
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message